(Q43613250)

English

A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies

scientific article published on 5 June 2013

In more languages
default for all languages
No label defined

No description defined

Statements

A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies (English)
Francis J Giles
Athos Gianella-Borradori
Blandine Longerey
Ekaterine Asatiani

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit